---
title: Opioid-Free Intraoperative Anesthesia (OFIA) With ACB + IPACK
version: 1.2
last-updated: 2025-12-07
---

# Opioid-Free Intraoperative Anesthesia (OFIA) With ACB + IPACK

## 1. Purpose
Provide a standardized opioid-free intraoperative anesthesia (OFIA) protocol for robot-assisted total knee arthroplasty (rTKA) using adductor canal block (ACB) and IPACK nerve block to optimize analgesia, minimize opioid requirements, reduce PONV, and support ERAS ambulation goals.

---

## 2. Preoperative Phase

### Patient Assessment
- ASA classification, airway exam, METs, allergies
- Review opioid tolerance history
- Review PONV/delirium history
- Frailty/cognition assessment for elderly
- ASRA-compliant anticoagulation review:
  - **DOACs:** last dose ≥72 hours if CrCl > 50 mL/min  
  - **Warfarin:** INR ≤1.4  
  - **Prophylactic LMWH:** ≥12 hours  
  - **Therapeutic LMWH:** ≥24 hours  

### Medications (ERAS-aligned)
- **Acetaminophen 1 g PO** (give 30-60 min pre-op)
- **Celecoxib 400 mg PO** (give 1-2 hours pre-op; or meloxicam 15 mg if NSAID alternative needed)
- **Dexamethasone 8–10 mg IV** (give after IV placement)
- **Scopolamine 1.5 mg patch** (evening prior or ≥2 hrs pre-op for high PONV risk)
- **Avoid gabapentinoids** (ASA/APSF 2024)

### Regional Blocks (Ultrasound-Guided)

**Pre-Block Anxiolysis:**
- **Midazolam 1–2 mg IV** before block placement (anxiolysis + amnesia)

**Adductor Canal Block (ACB):**
- 20–30 mL ropivacaine **0.2–0.25%**
- Ultrasound-guided, subsartorial approach
- Confirm negative aspiration

**IPACK Block:**
- 20 mL ropivacaine **0.2–0.25%**
- Between popliteal artery and posterior capsule
- Confirm negative aspiration

**Documentation:**
- Total ropivacaine dose (typically ~112.5 mg for 25 mL + 20 mL of 0.25%)
- Sensory coverage confirmed (quad-sparing, medial leg sensation)
- Motor function preserved (quadriceps strength intact)
- Patient comfort during procedure

---

## 3. Induction

**Pre-Oxygenation:**
- 100% FiO2 via tight-fitting mask for 3-5 minutes

**Induction Sequence:**
- **Midazolam 1–2 mg IV** (if not given for blocks, or additional 0.5-1 mg if already received for blocks and still anxious)
- **Propofol 1.5–2 mg/kg IV** (induction agent)
- **Ketamine 0.3–0.5 mg/kg IV** (NMDA antagonism, analgesia)
- **Rocuronium 0.6–1.0 mg/kg IV** (neuromuscular blockade; per airway plan)

**Optional Loading Doses:**
- **Dexmedetomidine 0.5 mcg/kg IV over 10–20 minutes** (if using infusion)
- **Magnesium sulfate 30–50 mg/kg IV over 15–20 minutes** (typical 40 mg/kg)

**Airway Management:**
- Endotracheal intubation or LMA per clinical judgment
- Confirm ETCO2 waveform
- Secure airway device

---

## 4. Maintenance

**Anesthetic Maintenance (Choose One):**
- **Sevoflurane 0.8–1.2 MAC** (preferred for ease of titration)
  - OR
- **Propofol TIVA 75–150 mcg/kg/min** (preferred for high PONV risk or MH susceptibility)

**Adjunct Infusions:**
- **Dexmedetomidine 0.2–0.7 mcg/kg/hr** (lower range 0.2-0.4 for elderly/frail)
- **Ketamine 0.1–0.25 mg/kg/hr**

**Hemodynamic Management:**
- **Maintain MAP >65 mmHg** (phenylephrine or ephedrine boluses PRN)
- Monitor for dexmedetomidine-related bradycardia (HR <50)
  - Treat with glycopyrrolate 0.2-0.4 mg IV preferred over atropine

**Key Principle:**
- **No intraoperative opioids**

**Monitoring:**
- Standard ASA monitors (ECG, NIBP, SpO2, ETCO2, temperature)
- Neuromuscular monitoring (TOF)
- Consider BIS/depth monitoring

---

## 5. Emergence

**10-15 Minutes Before End of Case:**
- Stop dexmedetomidine infusion (allow clearance)
- Continue ketamine infusion until skin closure complete

**At Skin Closure:**
- Stop ketamine infusion
- Reduce volatile agent or propofol infusion gradually

**Before Extubation:**
- **Ondansetron 4 mg IV** (PONV prophylaxis)
- **Sugammadex 2 mg/kg IV** if TOF shows residual blockade (or 4 mg/kg for deep block)

**Extubation Criteria:**
- Awake, following commands
- Adequate spontaneous ventilation (TV >5 mL/kg, RR 10-20)
- TOF ratio >0.9 (or >4 twitches if qualitative)
- Protective airway reflexes present

**Expected:**
- Smooth extubation due to OFIA regimen
- Minimal coughing/bucking
- Alert and oriented in PACU

---

## 6. Postoperative Phase

### Expected PACU Pain Scores
- **NRS 0–3/10** typical with functioning blocks
- If NRS ≥4, consider incomplete block or tourniquet pain

### Scheduled Analgesia
- **Acetaminophen 1 g PO/IV q6h**
- **NSAID of choice:**
  - Celecoxib 200 mg PO q12h, OR
  - Ketorolac 15 mg IV q6h (max 60 mg/day, limit to 48-72 hours), OR
  - Meloxicam 15 mg PO daily
- **No routine opioids expected**

### Rescue Analgesia (Stepwise)
1. **First-line:** Ketamine 0.1–0.15 mg/kg IV q10–15 min PRN
   - Max 3 doses (total ~0.3-0.45 mg/kg)
   - Monitor for dysphoria (rare at rescue doses)

2. **Second-line (if ketamine inadequate):**
   - Hydromorphone 0.2 mg IV q10-15 min PRN
   - Titrate carefully with reassessment after each dose
   - Use minimal effective total dose

### Mobilization
- **Target:** Ambulation on POD 0 (typically 4-6 hours post-op)
- Physical therapy evaluation when alert and pain controlled
- Quad-sparing blocks enable early mobilization

---

## 7. Notes

### Clinical Advantages
- **First-line pathway** for ERAS rTKA
- **Lowest nausea** (<10% PONV incidence)
- **Best early ambulation** (motor-sparing blocks)
- **Least delirium** (opioid-free approach)

### Ideal Patient Population
- Opioid-naïve patients
- Elderly (>70 years) - reduced delirium risk
- High PONV risk (females, non-smokers, history of motion sickness)
- Patients desiring rapid recovery and early discharge

### Key Principles
- **Midazolam provides anxiolysis** for block placement and does not compromise opioid-free principles
- **Propofol and sevoflurane are equally valid** maintenance choices based on patient factors and practitioner preference
- **Blocks last 12-18 hours** - transition to oral multimodal analgesia as they wear off
- **Postoperative opioid rescue available** when clinically indicated - does not constitute pathway failure

---

## References
See master reference file: `../../07_References_Evidence_2024.md`
